| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |